XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Note 6 - Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
  

Warrant shares outstanding

  

Weighted Average exercise price

  

Weighted Average remaining life

  

Intrinsic value

 
                 

Outstanding at January 1, 2023

  4,268,221   2.18   .50   - 

Issued

  -   -   -   - 

Exercised

  -   -   -   - 

Outstanding and exercisable at March 31, 2023

  4,268,221   2.18   .25   125,828 
Deferred Compensation Arrangement with Individual, Share-based Payments [Table Text Block]
  

March 31, 2023

  

March 31, 2022

 
         

Shares-to-be-issued, outstanding January 1, 2023 and 2022, respectively

  2,440,673   2,066,343 

Granted in current period

  78,125   108,148 

Issued in current period

  -   - 

Shares-to be issued outstanding March 31, 2023 and 2022, respectively

  2,518,798   2,174,491 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of Options

  

Weighted Averaged Exercise Price $

  

Weighted Average Remaining Contractual Life (Years)

  

Aggregate Intrinsic Options Value $

 

Options outstanding January 1, 2023

  3,059,989   2.36   6.38   - 

Granted during 2023

  -   -   -   - 

Exercised during 2023

  -   -   -   - 

Forfeited or expired during 2023

  -   -   -   - 

Options outstanding March 31, 2023

  3,059,989   2.36   6.13   - 

Exercisable, March 31, 2023

  1,081,651   2.16   4.55   - 
  

Number of Options

  

Weighted Averaged Exercise Price $

  

Weighted Average Remaining Contractual Life (Years)

  

Aggregate Intrinsic Options Value $

 

Options outstanding January 1, 2023

  91,663   1.75   2.55   1,083 

Granted during 2023

  8,333   0.89   4.99   - 

Exercised during 2023

  -   -   -   - 

Options outstanding March 31, 2023

  99,996   1.68   2.53   8,583 

Exercisable, March 31, 2023

  86,109   1.78   2.21   7,583 
Restricted Stock [Member]  
Notes Tables  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
  

Number of Shares

  

Weighted Average Grant-Date Fair Value per Award

 

Non-vested as January 1, 2023

  435,293   1.18 

Granted

  -   - 

Vested

  (192,835)  - 

Cancelled

      - 

Non-vested as March 31, 2023

  242,458   1.33